文献速递瓣膜外科

缘对缘技术在二尖瓣修复中的真实世界耐久性评估

Mitral valve repair using edge-to-edge technique in various situations: real-world experiences.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该真实世界研究纳入2002至2015年间303例至少中度二尖瓣反流并接受缘对缘二尖瓣修复的患者,评估该技术在不同情境下的耐久性。中位随访6.9年,手术死亡率为3.6%,二尖瓣事件率为18.5%。未行瓣环成形术是二尖瓣事件的唯一显著预测因素(HR 2.79),缺血性病因与累积生存率降低相关。

要点

  • 缘对缘修复可用于多种情境,包括持续性反流、SAM预防与治疗及经主动脉途径。
  • 未行瓣环成形术显著增加二尖瓣事件风险(HR 2.79)。
  • 缺血性病因患者无事件生存期最短(5.5年),需关注其长期预后。

核心结论

  • 缘对缘二尖瓣修复是一种多用途技术,在不同情境下应用可获得合理结局。
  • 缺血性病因与累积生存率降低相关,未行瓣环成形术与二尖瓣事件率升高相关。

研究设计与样本

  • 回顾性真实世界研究,纳入2002年1月至2015年5月间303例至少中度二尖瓣反流并接受缘对缘二尖瓣修复的患者。
  • 其中孤立性二尖瓣修复133例,合并冠状动脉旁路移植或其他瓣膜手术170例;中位随访6.9年(四分位距5.8年)。

主要发现

  • 二尖瓣反流病因以黏液样变性最常见(34%),其次为Barlow病(27.7%)和缺血性(21.5%)。
  • 缘对缘修复指征包括持续性反流(51.5%)、收缩期前向运动预防(22.1%)、经主动脉途径(17.5%)及术后收缩期前向运动治疗(8.9%)。
  • 224例(73.9%)同期行瓣环成形术;手术死亡率为3.6%,二尖瓣事件率为18.5%。
  • 生存率降低的显著预测因素包括年龄、肾功能不全、外周血管疾病和缺血性二尖瓣反流病因(均P < 0.050)。
  • 未行瓣环成形术是二尖瓣事件的唯一显著预测因素(HR 2.79;P < 0.001)。

临床怎么用

  • 缘对缘修复可灵活用于预防或治疗收缩期前向运动、经主动脉途径及合并其他手术情境。
  • 建议同期行瓣环成形术以降低二尖瓣事件风险。
  • 对缺血性病因患者应加强长期随访与风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Edge-to-edge (E2E) mitral valve repair (MVP) is a versatile technique used in various situations for mitral regurgitation (MR). This technique has been regaining attention, given the increasing use of the MitraClip procedure. This real-world study evaluates the durability of the E2E technique in different settings. METHODS: From January 2002 to May 2015, a total of 303 patients with at least moderate MR who underwent E2E MVP were identified. Patients undergoing isolated MVP (n = 133) and concomitant coronary artery bypass grafting or other valvular procedures (N = 170) were included. Cox proportional hazards modelling was used to evaluate the risk factors for cumulative survival, or MV event (i.e. MV reintervention or MR recurrence) while event-free survival-defined as time to composite outcome of either death or MV event-was determined using competing risk Kaplan-Meier analysis. Median follow-up duration was 6.9 (interquartile range 5.8) years. RESULTS: The most common MR aetiology was myxomatous (34%), followed by Barlow's disease (27.7%), and ischaemic (21.5%). E2E MVP was performed for the following indications: persistent MR (51.5%), systolic anterior motion prophylaxis (22.1%), transaortic approach (17.5%) and systolic anterior motion treatment post-MVP (8.9%). Concomitant ring annuloplasty was performed in 224 patients (73.9%). Operative mortality was 3.6% and MV event rate was 18.5%. Significant predictors of decreased survival included age, renal insufficiency, peripheral vascular disease and ischaemic MR aetiology (all P < 0.050). No ring annuloplasty (HR 2.79; P < 0.001) was the only significant predictor of MV events. Estimated event-free survival for the overall cohort was 8.5 years, and shortest for functional (non-ischaemic; 6.6 years) and ischaemic aetiology (5.5 years). CONCLUSIONS: E2E repair is a versatile MVP technique, which can be used in prevention and treatment of systolic anterior motion, transaortic approach or with concomitant techniques, with reasonable outcomes. Ischaemic aetiology and absence of ring annuloplasty were associated with worse cumulative survival and MV event rates, respectively, which raises some concern in light of the expanding indication for MitraClip system.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Hirji SA, Del Val FR, Yazdchi F, et al. Mitral valve repair using edge-to-edge technique in various situations: real-world experiences. Eur J Cardiothorac Surg. 2019. PMID: 31038670. doi:10.1093/ejcts/ezz130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。